[Treatment of patients with ulcer associated with Helicobacter pylori (experience with a triple therapy regimen].
The design of the medicamental treatment of the patients with duodenal ulcer disease associated with Helicobacter pylori is presented. It allows, as it was shown by our investigations, quickly to eliminate the pain in pyloroduodenal and (or) in epigastric areas and to achieve an adhesion of duodenal bulb ulcers according to the research protocol in 6 weeks. The eradication of Helicobacter pylori on the data of the fast urease test was determined in 9 of 10 patients. For getting more complete information about possibilities of using the given design of the medicamental preparations in the treatment of patients with duodenal ulcer disease associated with Helicobacter pylori, it is expedient to continue investigations in great numbers of the examined and treated patients.
Vasil'ev
Iu V
IuV
Central Research Institute of Gastroenterology, Moscow.
Kolomiets
E V
EV
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000382:microbiology; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use*; D008875:Middle Aged; D009853:Omeprazole / Q000627:therapeutic use*; D054328:Proton Pump Inhibitors
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D004791:Enzyme Inhibitors; D054328:Proton Pump Inhibitors; D008795:Metronidazole; D017291:Clarithromycin; D009853:Omeprazole
Lechenie bol'nykh iazvennoĭ bolezn'iu dvenadtsatiperstnoĭ kishki, assotsiirovannoĭ s Helicobacter pylori (opyt primeneniia odnoĭ iz skhem troĭnoĭ terapii).